Medtronic Stock Outlook: Is Wall Street Bullish or Bearish?

With a market cap of $99.9 billion, Medtronic plc (MDT) is a global medical technology company that develops, manufactures, and sells device-based therapies to healthcare providers and patients worldwide. The Ireland-based company operates across cardiovascular, neuroscience, medical-surgical, and diabetes care, offering innovative solutions that address a wide range of chronic and acute conditions.

MDT has faced challenges, and its shares have lagged behind the broader market over the past 52 weeks. MDT stock has dipped 6.8% over this time frame, while the broader S&P 500 Index ($SPX) has gained 28.5%. Moreover, the stock has fallen 19% on a YTD basis, trailing the index’s 6% rise.